Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

γδ T cells adapt uniquely to different tissues in mice.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Targeting regulatory T cells may help treat age-related diseases.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

A new mouse model effectively mimics vitiligo for research and drug testing.

Inflammation damages sweat ducts, causing sweat gland injury.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

IL-17 and certain immune cells are linked to more severe alopecia areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Different γδ T cell types have unique roles in causing alopecia areata.

Targeting specific T cells may help treat alopecia areata.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.